Home/Natco Pharma/Aditya Nannapaneni
AN

Aditya Nannapaneni

Director

Natco Pharma

Natco Pharma Pipeline

DrugIndicationPhase
Generic Lenalidomide (Revlimid)Multiple Myeloma, Myelodysplastic SyndromesLaunched
Generic Oseltamivir (Tamiflu)InfluenzaLaunched
Generic Glatiramer Acetate (Copaxone)Multiple SclerosisLaunched
Generic Imatinib (Gleevec)Chronic Myeloid Leukemia, Gastrointestinal Stromal TumorLaunched
Portfolio of Oncology Injectables (e.g., Pemetrexed, Bortezomib)Various CancersANDA Filed / Development
Hepatitis C Antiviral CombinationsHepatitis C Virus InfectionLaunched
Generic Oxycodone ER (Oxycontin)Pain ManagementLaunched